Return to Today's science sparks archives
Click the tweet icon above each article title to share it on Twitter.
|
Fig. 1 Edge modulation during phenotypic change in EMT.
|
 |
|
Fig. 3 Crystal structure of an anti-EphA2 scFv Ab in complex with the ligand-binding domain of EphA2.
|
|
|
Fig. 1 Regulation of cannibalism and entosis.
|
|
|
Fig. 1 Chest radiograph (postoperative day 9) demonstrating a moderate left hydropneumothorax with left lower lobe atelectasis, right lower lung consolidation, persistent postsurgical changes of esophagectomy, and left upper abdomen prominent loop of bowel.
|
|
|
Fig. 3 Sensitizing RT transcriptionally primes pancreatic cancer cells for TRAIL-induced death.
|
|
|
Fig. 1 A subset of activated Treg cells expresses CD49b and is enriched in vasculature and skin.
|
|
|
Fig. 9 Map of life expectancy for both sexes in 2040 based on the reference forecast.
|
|
|
Fig. 2 Detection of GNP-amounts in murine spinal cords with XFI vs. ICP-MS.
|
|
|
Fig. 1 Genetic clustering of bacterial Lhr-Core and three putative nucleic acid repair enzymes.
|
|
|
Fig. 1 PPP1R35 is enriched on daughter centrioles.
|
|
|
Fig. 1 Hypothetical example of a spider plot showing tumor growth or shrinkage from baseline in a cohort of patients.
|
|
|
Fig. 1 Mechanisms of immunotherapy combinations in gynecological cancers.
|
|
|
Fig. 1 Putative interactions between the intestinal and/or lung microbiome and the host that could influence the outcome of M. tuberculosis (Mtb) infection and treatment.
|
|
|
Fig. 2 Three scenarios of the relation between mediastinal disease and the heart.
|
|
|
Fig. 1 Different views of conduit perfusion assessment using indocyanine green fluorescence imaging.
|
|
|
Fig. 4 Sensitivity and specificity of mass spectrometry search algorithms.
|
|
|
Fig. 1 A temporal switch in the requirements for Mad1-Mad2 targeting to kinetochores during SAC signaling.
|
|
|
Fig. 1 HS-AFM structural titration experiments with GLIC channels.
|
|
|
Fig. 1 Tumor copy number landscape of conservatively treated primary prostate cancer, compared to other primary prostate cancer cohorts.
|
|
|
Fig. 6 Model for dual control of RecA catalyzed LexA cleavage through phosphorylation and cardiolipin converging on Loop 2 S207.
|
|
|
Fig. 3 Rates of testicular cancer.
|
|
|
Fig. 1 Repeated LTEE in ammonium-limited chemostats selects for adaptive mutations in GAT1.
|
|
|
Fig. 1 Baseline tumor size, elevated LDH, and sites of distant metastases are emerging prognostic indicators of shorter overall survival in patients with melanoma treated with anti-PD-1 therapy.
|
|
|
Fig. 3 Typical k‐space sampling patterns utilized in CS for mapping of the knee cartilage.
|
|
|
Fig. 3 Exercise modulates functional connectivity strength between the right superior parietal gyrus and the left postcentral gyrus post-HDBR.
|
|
|
Fig. 1 Temporal sequence of events taking place in embryos recapitulated in pluripotent stem cells.
|
|
|
Fig. 3 Digital diffraction diagnosis (D3) platform for rapid diagnosis of biopsy material in resource‐limited settings.
|
|
|
Fig. 1 Heterogeneity of group 1 ILCs.
|
|
|
Fig. 1 aCGH+SNP analysis. (A) Chromosome ideogram of all alterations detected in myelofibrosis (MF) spleens from 13 patients.
|
|
|
Fig. 1 HOXA9 binds to active enhancers in HMM and in HMB cells.
|
|
|
Fig. 1 CD19 antigen escape from CAR T cell therapy.
|
|
|
Fig 4 Representative 2D marginal distributions of pairs of thermodynamic properties from Bayesian ITC analysis.
|
|
|
Fig. 2 A 73‐year old male underwent resection of osteoradionecrosis of the right hemimandible with planned free osteocutaneous fibula flap reconstruction.
|
|
|
Fig. 1 Screen shots of representative cards of Thyroid Cancer Treatment Choice.
|
|
|
Fig. 1 The conceptual map demonstrates that an overused service can lead directly to short-term and/or long-term negative consequences for patients across 6 domains.
|
|
|
Fig. 1 Immunograms of baseline and dynamic biomarkers.
|
|
|
Fig. 1 (a) Dose distribution in the axial plane for a free breathing plan. (b) Dose distribution in the corresponding axial plane for a DIBH plan.
|
|
|
Fig. 1 RslTpt1 genetic organization and tRNA 2′-phosphotransferase activity in yeast.
|
|
|
Fig. 1 Coronal computed tomography image of the thorax of a patient with lymphoblastic lymphoma.
|
|
|
Fig. 1 Cryo-EM map and overall structure of CeMCU.
|
|
|
Fig. 1 Ablation of PCs at P1 stimulates their replenishment and development of normal CB size and morphology.
|
|
|
Fig. 1 Schematic representation of the extended RCR assay. The amplification phase allows any existing virus to increase.
|
|
|
Fig. 3 (A) A positive ion chromatogram showing baseline separation of isobaric and structurally related compounds that have the potential to interfere with estradiol and testosterone. (B) A negative ion chromatogram showing baseline separation of isobaric and structurally related compounds that have the potential to interfere with estradiol and testosterone.
|
|
|
Fig. 8 Nrf2 and IL-17D mediate recruitment of innate immune cells to the peritoneum after MCMV infection.
|
|
|
Fig. 1 The quiescent conformation –latched with a closed pore.
|
|
|
Fig. 1 Timeline of neurotoxicity (NTX) and association with CRS after conditioning chemotherapy and 19-28z CAR T-cell infusion.
|
|
|
Fig. 2 FGFR2 gene fusions. Multiple fusion partners with FGFR2 were identified, the most frequent being BICC1 and KIAA1217.
|
|
|
Fig. 1 Mechanism of action of PARP inhibition.
|
|
|
Fig. 1 Generation of DICER1 conditional knockout hESC lines.
|
|
|
Fig. 1 The SUMO protease Ulp1_WT (colored) is shown in complex with a substrate SUMO protein Smt3 (gray).
|
|
|
Fig. 1 Mouse CAR-T cells can be co-modified to secrete the mouse PD-1-blocking scFv RMP1-14.
|
|
|
Fig. 4 Hypothetical model for ATM-mediated DSB control.
|
|
|
Fig. 5 Measurement of kinetochore spindle fibers at metaphase of in MDA-MB-231-LM2-4175 cells expressing α-tubulin mutants.
|
|
|
Fig. 1A 68-year-old man with prostate cancer.
|
|
|
Fig. 3 Arid1a is not required for maintenance of acinar cells in the setting of wild-type Kras.
|
|
|
Fig. 1 Targeting leukemia repopulating cells for a durable remission.
|
|
|
Fig. 7 Model for acquired resistance of BRAF-ATCs to inhibition of the oncogenic driver.
|
|
|
Fig. 1 Supervised clustering showing 90 differentially expressed microRNAs between HCC and normal liver and between HCA and normal liver tumors.
|
|
|
Fig. 1 Distribution of Recurrence Score result by tumor subtype using standard cutoffs.
|
|
